Recommendation
Wake-Up Call: Managing OSA with Smarter Solutions
Boost your ability to manage obstructive sleep apnea (OSA) with strategies that go beyond the basics. Explore tools to improve CPAP adherence, incorporate weight loss to reduce complications, and apply new therapies and devices—empowering you to deliver more effective, patient-centered care for this common and impactful condition.
CME/CE Information
0.75 AMA PRA Category 1 Credits™, 0.75 ABIM MOC or 0.63 AANP, including 0.63 AANP Pharm
Release Date: 8/29/2025
Expiration Date: 8/29/2026
Recommended Based on Your Feedback
When you begin, you’ll be asked a quick baseline question to help tailor your educational journey. This helps us recommend content that best matches your current knowledge and ensures the learning path is as relevant and effective as possible.
CPAP Therapy Mastery
Faculty:
Vani Potluri, MD
Katherine Sharkey, MD, PhD, FAASM, FACP
Pharmacotherapy Deep Dive
Faculty:
Vani Potluri, MD
Katherine Sharkey, MD, PhD, FAASM, FACP
Non-pharmacologic Therapies Beyond CPAP
Faculty:
Vani Potluri, MD
Katherine Sharkey, MD, PhD, FAASM, FACP
Learning Objectives
- Examine the currently available treatment modalities for OSA, with a focus on improving CPAP adherence, promoting patient-centered care, and leveraging recently approved pharmacotherapy and devices
- Incorporate weight loss into comprehensive OSA management plans to reduce disease severity and associated complications
Faculty
Vani Potluri, MD
Assistant Professor of Medicine, Section of General Internal Medicine, Baylor College of Medicine, Houston, Texas
Katherine Sharkey, MD, PhD, FAASM, FACP
Associate Professor of Medicine, The Warren Alpert Medical School of Brown University, Associate Professor of Psychiatry & Human Behavior
Disclosures
All individuals in control of content for this activity (including faculty, moderator, editors, reviewers) have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 0.63 contact hour of continuing education, which includes 0.63 hours of pharmacology.
Supported By
This activity is supported by an educational grant from Lilly
Education Partner
Pri-Med Institute